192 related articles for article (PubMed ID: 8911656)
41. Sodium ions modulate differentially the effect of a benzodiazepine agonist on rat spinal mu-, delta- and kappa-opioid receptors.
Rattan AK; Tejwani GA
Pharmacology; 1994 Jan; 48(1):30-40. PubMed ID: 8309985
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
43. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
44. Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.
Hurley RW; Grabow TS; Tallarida RJ; Hammond DL
J Pharmacol Exp Ther; 1999 May; 289(2):993-9. PubMed ID: 10215679
[TBL] [Abstract][Full Text] [Related]
45. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
46. Effects of tramadol on motor and sensory responses of the spinal nociceptive system in the rat.
Carlsson KH; Jurna I
Eur J Pharmacol; 1987 Jul; 139(1):1-10. PubMed ID: 3653236
[TBL] [Abstract][Full Text] [Related]
47. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
48. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
[TBL] [Abstract][Full Text] [Related]
49. Implications of Ca(2+)-activated Cl(-) channels in the delta-opioid receptor-mediated antinociception in the mouse spinal cord.
Yamazaki M; Mizoguchi H; Ohsawa M; Tseng LF; Suzuki T; Narita M
Neurosci Lett; 2000 Dec; 295(3):113-5. PubMed ID: 11090987
[TBL] [Abstract][Full Text] [Related]
50. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
51. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
52. The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat.
Tseng LF; Henneberry B; Collins KA
Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):464-8. PubMed ID: 7643909
[TBL] [Abstract][Full Text] [Related]
53. Contribution of spinal mu(1)-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar.
Mizoguchi H; Ito K; Watanabe H; Watanabe C; Katsuyama S; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Nov; 27(11):2786-93. PubMed ID: 16919848
[TBL] [Abstract][Full Text] [Related]
54. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
55. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
56. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
57. Interactions of galanin and morphine in the spinal antinociception in rats with mononeuropathy.
Zhang YP; Lundeberg T; Yu LC
Brain Res; 2000 Jan; 852(2):485-7. PubMed ID: 10678779
[TBL] [Abstract][Full Text] [Related]
58. Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced antinociception in diabetic mice.
Ohsawa M; Kamei J
Eur J Pharmacol; 1997 Nov; 339(1):27-31. PubMed ID: 9450613
[TBL] [Abstract][Full Text] [Related]
59. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
60. Antinociception produced by an ascending spino-supraspinal pathway.
Gear RW; Levine JD
J Neurosci; 1995 Apr; 15(4):3154-61. PubMed ID: 7722653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
